Status:
UNKNOWN
Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Glaucoma, Open-Angle
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
To compare the effect of intraocular pressure control and the incidence of peripheral anterior synechia between CLASS combined with phacoemulsification and CLASS alone in the treatment of primary open...
Detailed Description
Group A: CO2 Laser-Assisted Sclerectomy Surgery combined with phacoemulsification; Group B: simple CO2 Laser-Assisted Sclerectomy Surgery. The patients were followed up for 1 year. The incidence of pe...
Eligibility Criteria
Inclusion
- Primary open-angle glaucoma patients with cataract in our Ophthalmic Center;
- Topical use of hypotensive drugs in the treatment of poor or intolerable intraocular pressure control;
- The patients were aged from 50 to 80 years old, regardless of gender;
- Class operation and phacoemulsification were performed;
- Patients are able and willing to comply with the research guidance and may complete all visits required by the research;
- Informed consent has been signed.
Exclusion
- Allergic to any perioperative medication in this study;
- History of ocular trauma;
- Any previous intraocular surgery;
- Angle of the chamber was narrow by angle microscopy (Schaffer grade III and below);
- Patients diagnosed as secondary glaucoma;
- Optic atrophy caused by other reasons;
- The serious complications such as posterior capsule rupture and choroidal hemorrhage occurred during the operation;
- Serious complications of eyes occurred after operation;
- The patient's history indicated that he had severe dysfunction of heart, lung, liver and kidney;
- Women in pregnancy, lactation or planned pregnancy;
- The researchers believe that the patient's condition may put the patient at significant risk, and may confuse the research results.
Key Trial Info
Start Date :
September 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04920227
Start Date
September 2 2020
End Date
August 1 2023
Last Update
June 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Center, the 2nd Affiliated Hospital, Medical College of Zhejiang University
Hangzhou, Zhejiang, China